ALT
NASDAQ · Biotechnology
Altimmune Inc
$3.31
+0.04 (+1.22%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+218.7% upside
Low Target
$6.68
Average Target
$10.55
High Target
$11.58
Current Price
$3.31
Current
$3.31
$3.31
Target
$10.55
$10.55
$6.68
$10.55 avg
$11.58
Scenario Analysis
Bear Case
$6.68
101.8%
Low target
Base Case
$10.55
+218.7%
Avg target
Bull Case
$11.58
+249.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$6.44
-48.6% from high
52-Week Low
$2.56
+29.3% from low
Target vs 52W High
$10.55
+63.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |